文章基本信息

标题：Connecting Discovery and Delivery: The Need For More Evidence on Effective Smoking Cessation Strategies for People Living With HIV/AIDS
本地全文：下载
作者：Jenine K. Harris
期刊名称：American journal of public health
印刷版ISSN：0090-0036
出版年度：2010
卷号：100
期号：7
页码：1245-1249
DOI：10.2105/AJPH.2009.172460
语种：English
出版社：American Public Health Association
摘要：Smoking prevalence among the 1.1 million Americans living with HIV/AIDS is 2 to 3 times higher than the 19.8% rate among the general population. Since 1990, scientists have worked toward the discovery of health risks related to smoking in people living with HIV/AIDS; however, few studies have evaluated the delivery of smoking cessation interventions for this population. Increasing linkages between discovery science and delivery science may facilitate a faster transition to delivery of smoking cessation interventions for people living with HIV/AIDS. Health research often focuses on the discovery of risk factors associated with disease and death.¹ Although discovery of health risks is necessary to protect health, the delivery of interventions to improve health is equally important.^{1 – 5} Information regarding how science moves from discovery to delivery points to substantial time lag and little cross-talk between discovery and delivery research.^{1 , 6} This may be especially problematic in areas such as HIV/AIDS and smoking, where delay between discovery of smoking-related health outcomes in people living with HIV/AIDS and the delivery of interventions to reduce smoking among this population has serious consequences. Smoking prevalence in people living with HIV/AIDS is 2 to 3 times higher than is the 19.8% rate among the general population.^{7 – 16} Discovery research has concluded that smokers with HIV/AIDS are more likely to be nonadherent to treatment, have a greater chance of being diagnosed with an AIDS-defining condition or dying, and report lower quality of life than do nonsmoking persons with HIV/AIDS.^{13 , 17 – 21} Smokers living with HIV/AIDS have a higher risk of disease and opportunistic infection than do smokers who do not have HIV/AIDS.^{9 , 22 – 34} Delivery research indicates that population-specific smoking cessation interventions can be effective.^{35 – 52} Although few studies have examined such strategies for persons living with HIV/AIDS,³⁵ a recent study found that 86% of smokers with HIV/AIDS would not benefit from standard cessation programs.⁵³ I used citation network analysis^{54 – 56} to examine the characteristics of—and possible relationships between—discovery research relating health outcomes to smoking in persons living with HIV/AIDS and delivery research on interventions to reduce smoking among this population.